Intellectual Property Cases filed in Delaware
Cases 11 - 20 of 24
Novo Nordisk Inc. et al v. Sun Pharmaceutical Industries Ltd. et al
as 1:2022cv00896
Plaintiff: Novo Nordisk Inc. and Novo Nordisk A/S
Defendant: Sun Pharmaceutical Industries Ltd. and Sun Pharmaceutical Industries, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Novo Nordisk Inc. et al v. Orbicular Pharmaceutical Technologies Pvt. Ltd.
as 1:2022cv00856
Plaintiff: Novo Nordisk Inc. and Novo Nordisk A/S
Defendant: Orbicular Pharmaceutical Technologies Pvt. Ltd.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Novo Nordisk A/S et al v. Sun Pharmaceutical Industries Ltd. et al
as 1:2022cv00296
Plaintiff: Novo Nordisk A/S and Novo Nordisk Inc.
Defendant: Sun Pharmaceutical Industries Ltd. and Sun Pharmaceutical Industries Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Novo Nordisk Inc. et al v. Aurobindo Pharma USA, Inc. et al
as 1:2022cv00295
Plaintiff: Novo Nordisk Inc. and Novo Nordisk A/S
Defendant: Aurobindo Pharma USA, Inc., Aurobindo Pharma Ltd. and Eugia Pharma Specialties Ltd.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Novo Nordisk Inc. et al v. Rio Biopharmaceuticals, Inc. et al
as 1:2022cv00294
Plaintiff: Novo Nordisk Inc. and Novo Nordisk A/S
Defendant: Rio Biopharmaceuticals, Inc. and EMS S/A
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Novo Nordisk Inc. et al v. Zydus Worldwide DMCC et al
as 1:2022cv00297
Plaintiff: Novo Nordisk Inc. and Novo Nordisk A/S
Defendant: Zydus Worldwide DMCC, Zydus Pharmaceuticals (USA) Inc. and Cadila Healthcare Ltd.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Novo Nordisk Inc. et al v. Dr. Reddy's Laboratories Ltd. et al
as 1:2022cv00298
Plaintiff: Novo Nordisk Inc. and Novo Nordisk A/S
Defendant: Dr. Reddy's Laboratories Ltd. and Dr. Reddy's Laboratories Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Novo Nordisk Inc. et al v. Alvogen, Inc.
as 1:2022cv00299
Plaintiff: Novo Nordisk Inc. and Novo Nordisk A/S
Defendant: Alvogen, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Novo Nordisk Inc. et al v. Teva Pharmaceuticals, Inc. et al
as 1:2021cv01782
Defendant: Teva Pharmaceuticals, Inc., Teva Pharmaceuticals Development, Inc. and Teva Pharmaceuticals USA, Inc.
Plaintiff: Novo Nordisk Inc. and Novo Nordisk A/S
Cause Of Action: 35 U.S.C. § 271
Novo Nordisk Inc. et al v. Hikma Pharmaceuticals USA Inc.
as 1:2021cv01783
Plaintiff: Novo Nordisk Inc. and Novo Nordisk A/S
Defendant: Hikma Pharmaceuticals USA Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.


Why Is My Information Online?